on 13 Mar 2019
Last Applicant/ Owned by
London W1W 6XB
GB
Serial Number
79066961 filed on 13th Mar 2009
Registration Number
3742666 registered on 26th Jan 2010
Correspondent Address
CYNTHIA C. WEBER
Filing Basis
No Filing Basis
Disclaimer
"THERAPEUTICS"
The mark consists of an outer arc in the color blue and a concentric inner arc in the color yellow. To the right of the arcs appears the term "ARK" in the color blue over the term "THERAPEUTICS" also in blue. Pharmaceutical preparations for the treatment of wounds, burns, vascular and circulatory system related diseases, cancer, malignant glioma and other malignant brain tumours, macular degeneraRead More
Diagnostic protein preparations for use in science, scientific diagnostics and industry; diagnostic preparations of genes for use in science, scientific diagnostics and industry
Pharmaceutical preparations for the treatment of wounds, burns, vascular and circulatory system related diseases, cancer, malignant glioma and other malignant brain tumours, macular degeneration, lipodystrophy and other metabolic conditions associated with the use of anti-HIV therapy, cachexia and muscle wasting; pharmaceutical preparations for the prevention of stenosis, namely, stenosis caused by intimal hyperplasia following surgical procedures; pharmaceutical preparations to promote or suppress angiogenesis and enhance blood flow; pharmaceutical preparations for increasing the efficiency of muscle cell energy production; therapeutic agents for the treatment of wounds, burns, vascular and circulatory system related diseases, cancer, malignant glioma and other malignant brain tumours, macular degeneration, lipodystrophy and other metabolic conditions associated with the use of anti-HIV therapy, cachexia and muscle wasting; therapeutic agents for the prevention of stenosis, namely, stenosis caused by intimal hyperplasia following surgical procedures; therapeutic agents to promote or suppress angiogenesis and enhance blood flow; therapeutic agents for increasing the efficiency of muscle cell energy production; diagnostic preparations for medical purposes; protein preparations for clinical or medical laboratory use, namely for targeting therapeutic agents to specific sites; medical dressings; surgical dressings; burn dressings; wound dressings; absorbent wound and burn dressings in the nature of pads; foot and hand dressings for medical purposes; fluid handling foot and hand dressings for medical purposes; preparations of genes for therapeutics purposes namely for the treatment of wounds, burns, vascular and circulatory system related diseases, cancer, malignant glioma and other malignant brain tumours, macular degeneration, lipodystrophy and other metabolic conditions associated with the use of anti-HIV therapy, cachexia and muscle wasting; preparations of genes for therapeutic purposes namely for the prevention of stenosis, namely, stenosis caused by intimal hyperplasia following surgical procedures; preparations of genes for therapeutic purposes namely to promote or suppress angiogenesis and enhance blood flow; preparations of genes for therapeutic purposes namely for increasing the efficiency of muscle cell energy production
Boots and gloves for orthopaedic and medical purposes; boots and gloves for medical purposes with the ability to handle wound fluid; boots and gloves for medical use and absorbent filters, liners and inserts for use therewith; filters, soles and absorbent inserts for socks, boots and gloves for medical purposes, namely, for the treatment of wounds and burns; foot and hand dressings for medical purposes, namely, for the treatment of wounds and burns; parts and fittings for all the aforesaid goods
Scientific, medical and clinical research, all in the field of the treatment of wounds, burns, vascular and circulatory system related diseases, cancer, malignant glioma and other malignant brain tumours, macular degeneration, lipodystrophy and other metabolic conditions associated with the use of anti-HIV therapy, cachexia and muscle wasting, prevention of stenosis, increasing the efficiency of muscle cell energy production and promoting or suppressing angiogenesis and enhancing blood flow; scientific, medical and clinical research for the discovery, design, creation, development and testing in the field of pharmaceutical preparations and therapeutically active substances; scientific, medical and clinical research in the field of gene therapy; scientific, medical and clinical research for the discovery, design, creation, development and testing in the field of pharmaceutical preparations and therapeutically active substances for use in the field of gene therapy; advisory services relating to the aforesaid services; scientific, medical and clinical research in the field of genes and genetics; medical and scientific research, namely, conducting gene therapy trials; provision of information relating to the above
No 79066961
No Service Mark
No
No
No
No
No
No
No
No
No
26.17.09 -
Curved line(s), band(s) or bar(s)
The mark consists of an outer arc in the color blue and a concentric inner arc in the color yellow. To the right of the arcs appears the term "ARK" in the color blue over the term "THERAPEUTICS" also in blue.
| Status Date | Action Taken |
|---|---|
| 11th Oct 2019 | DEATH OF INTERNATIONAL REGISTRATION |
| 11th Oct 2019 | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED |
| 16th Jun 2017 | TOTAL INVALIDATION PROCESSED BY THE IB |
| 11th May 2017 | INVALIDATION PROCESSED |
| 11th May 2017 | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB |
| 02th May 2017 | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED |
| 02th Sep 2016 | CANCELLED SECTION 71 |
| 07th Feb 2013 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| 24th May 2010 | FINAL DISPOSITION NOTICE SENT TO IB |
| 24th May 2010 | FINAL DISPOSITION PROCESSED |
